This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Van der Linden, P. Articles by Vincent, J.-L. Search for Related Content PubMed PubMed Citation Articles by Van der Linden, P. Articles by Vincent, J.-L.

Comparison of Halothane, Isoflurane, Alfentanil, and Ketamine in Experimental Septic Shock

From the Departments of Anesthesiology and Intensive Care, Erasme University Hospital, Free University of Brussels, Brussels, Belgium.

Abstract

The effects of four commonly used anesthetic agents, halothane, isoflurane, alfentanil, and ketamine, on cardiovascular function and oxygen balance were studied in a dog model of septic shock. After initial pentobarbital administration, the dogs were given Escherichia coli endotoxin (3 mg/kg) and, after 30 min, fluids to restore cardiac filling pressures to baseline levels. This resulted in a low resistance shock in all animals. Dogs were then given for 2 h either halothane (n = 9, 0.5 MAC), isoflurane (n = 9, 0.5 MAC), or alfentanil (n = 9, 150 µg/kg IV plus 2 mg·kg^–1·min^–1) or ketamine (n = 9, 2 mg/kg IV plus 0.2 mg·kg^–1·min^–1) or no anesthetic (control: n = 9). Mean arterial pressure increased in the control group (+11 ± 18 mm Hg) and with ketamine (+10 ± 20 mm Hg), remained unchanged with isoflurane (–2 ± 11 mm Hg), and decreased with halothane (–22 ± 23 rnm Hg) and alfentanil (–9 ± 23 mm Hg). Heart rate tended to increase in the control group but decreased with the four anesthetic agents, especially with alfentanil and halothane. Cardiac index and left ventricular stroke work index increased in the control group and in each anesthetic group except the halothane group. Systemic vascular resistance decreased in all groups except in the ketamine group. In the control group, the increase in cardiac index was associated with significant increases in oxygen delivery and consumption, and with a significant decrease in blood lactate levels. There was a dramatic decrease in oxygen consumption in all anesthetic groups, whereas oxygen delivery failed to increase only with halothane. Blood lactate increased significantly with halothane (5.0 ± 1.5 to 6.3 ± 1.4 mM/L) and isoflurane (4.8 ± 1.1 to 5.3 ± 1.2 mM/L), remained unchanged with alfentanil (4.5 ± 1.5 and 4.6 ± 0.8 mM/L), and tended to decrease with ketamine (4.9 ± 1.4 to 4.5 ± 1.4 mM/L). In conclusion, among the four anesthetic agents tested, halothane had the least desirable effects. Ketamine best preserved cardiovascular function and appeared to have the least deleterious effects on the hypoxic tissues. Thus, ketamine could be the anesthetic agent of choice in septic shock.

Key Words: ANESTHETICS, INTRAVENOUS—alfentanil, ketamine • ANESTHETICS, VOLATILE—halothane, isoflurane • SHOCK, SEPTIC—IV and inhalation anesthetics

This article has been cited by other articles:

				F. Aroni, N. Iacovidou, I. Dontas, C. Pourzitaki, and T. Xanthos Pharmacological Aspects and Potential New Clinical Applications of Ketamine: Reevaluation of an Old Drug J. Clin. Pharmacol., August 1, 2009; 49(8): 957 - 964. [Abstract] [Full Text] [PDF]

				G. Zilberstein, R. Levy, M. Rachinsky, A. Fisher, L. Greemberg, Y. Shapira, A. Appelbaum, and L. Roytblat Ketamine Attenuates Neutrophil Activation After Cardiopulmonary Bypass Anesth. Analg., September 1, 2002; 95(3): 531 - 536. [Abstract] [Full Text] [PDF]

				B. Allaouchiche, F. Duflo, J.-P. Tournadre, R. Debon, and D. Chassard Influence of sepsis on sevoflurane minimum alveolar concentration in a porcine model{{dagger}} Br. J. Anaesth., June 1, 2001; 86(6): 832 - 836. [Abstract] [Full Text] [PDF]

				M. A. Weigand, H. Schmidt, Q. Zhao, K. Plaschke, E. Martin, and H. J. Bardenheuer Ketamine Modulates the Stimulated Adhesion Molecule Expression on Human Neutrophils In Vitro Anesth. Analg., January 1, 2000; 90(1): 206 - 206. [Abstract] [Full Text] [PDF]

				T. Kawasaki, M. Ogata, C. Kawasaki, J.-i. Ogata, Y. Inoue, and A. Shigematsu Ketamine Suppresses Proinflammatory Cytokine Production in Human Whole Blood In Vitro Anesth. Analg., September 1, 1999; 89(3): 665 - 665. [Abstract] [Full Text] [PDF]